3 Big Pharma Stocks Set to Succeed

That disclaimer that the Securities and Exchange Commission requires mutual funds to provide to investors isn't one to overlook: Past performance really may not be indicative of future results. This applies to mutual funds and to individual stocks.

For big pharma stocks, though, you can get a sense for what their prospects could look like. Current products and pipeline candidates can help investors determine which stocks have the best chances at being winners. In my view, three big pharma stocks look set to succeed: AbbVie (NYSE: ABBV), Allergan (NYSE: AGN), and Celgene (NASDAQ: CELG). Here's why.

Image source: Getty Images.

Continue reading


Source: Fool.com